Patent · US Active

Compound, probe containing the novel compound, and fluorescence-imaging contrast agent containing the novel compound or the probe

US8293782B2 · kind B2 · utility

0Cited by
7References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 29, 2010
Grant dateOct 23, 2012
Priority date
Expiry dateFeb 16, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D209/60
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound represented by Formula (1) below,where n is 2 or 3; a is an integer of 1 to 4 and b is an integer of 3 and 5 to 10, or a is 5 and b is an integer of 1 to 10; R1 to R8 each independently represent a hydrogen atom or a sulfonate that is any one of sodium sulfonate, potassium sulfonate, ammonium sulfonate, triethylammonium sulfonate, pyridinium sulfonate, lysine sulfonate, and arginine sulfonate; and R9 to R12 each independently represent a substituted or unsubstituted C1-C3 alkyl group.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.